Neurobiology of Aging
Volume 27, Issue 7 , Pages 955-964 , July 2006

Activity changes and marked stereotypic behavior precede A pathology in TgCRND8 Alzheimer mice

  • Oliver Ambrée

      Affiliations

    • Department of Behavioural Biology, University of Münster, Badestr. 9, D-48149 Münster, Germany
    • Institute of Neuropathology, University Hospital Münster, Domagkstr. 19, D-48149 Münster, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 251 83 24783; fax: +49 251 83 23896.
    • ,
  • Chadi Touma

      Affiliations

    • Department of Behavioural Biology, University of Münster, Badestr. 9, D-48149 Münster, Germany
    • Present address: Max Planck Institute of Psychiatry, Kraepelinstr. 2, D-80804 Munich, Germany.
    • ,
  • Nicole Görtz

      Affiliations

    • Department of Behavioural Biology, University of Münster, Badestr. 9, D-48149 Münster, Germany
    • ,
  • Kathy Keyvani

      Affiliations

    • Institute of Neuropathology, University Hospital Münster, Domagkstr. 19, D-48149 Münster, Germany
    • ,
  • Werner Paulus

      Affiliations

    • Institute of Neuropathology, University Hospital Münster, Domagkstr. 19, D-48149 Münster, Germany
    • ,
  • Rupert Palme

      Affiliations

    • Institute of Biochemistry, University of Veterinary Medicine Vienna, Veterinärplatz 1, A-1210 Vienna, Austria
    • ,
  • Norbert Sachser

      Affiliations

    • Department of Behavioural Biology, University of Münster, Badestr. 9, D-48149 Münster, Germany

Received 2 March 2005 ,Revised 3 May 2005 ,Accepted 11 May 2005.

References 

  1. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE,, et al. Age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 2001;891(1–2):42–53
  2. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex. 1991;1(1):103–116
  3. Ashe KH. Learning and memory in transgenic mice modeling Alzheimer’s disease. Learn Mem. 2001;8(6):301–308
  4. Beynen AC. Communication between rats of experiment-induced stress and its impact on experimental results. Anim Welf. 1992;1:153–159
  5. Cabib S. Neurobiological basis of stereotypies. In: Lawrence AB, Rushen J, editors. Stereotypic animal behaviour: fundamentals and applications to welfare. Wallingford: CAB International; 1993. p. 119–46.
  6. Chapman PF, Falinska AM, Knevett SG, Ramsay MF. Genes, models and Alzheimer’s disease. Trends Genet. 2001;17(5):254–261
  7. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J,, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem. 2001;276(24):21562–21570
  8. Cooper JJ, Ödberg F, Nicol CJ. Limitations on the effectiveness of environmental improvement in reducing stereotypic behaviour in bank voles (Clethrionomys glareolus). Appl Anim Behav Sci. 1996;48:237–248
  9. Cooper SJ, Dourish CT. An introduction to the concept of stereotypy and a historical perspective on the role of brain dopamine. In: Cooper SJ, Dourish CT, editors. Neurobiology of stereotyped behaviour. Oxford: Clarendon Press; 1990. p. 1–24.
  10. Cross AJ, Crow TJ, Ferrier IN, Johnson JA, Markakis D. Striatal dopamine release in Alzheimer-type dementia. Neurosci Lett. 1984;52:1–6
  11. Cummings BJ, Pike CJ, Shankle R, Cotman CW. -Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer’s disease. Neurobiol Aging. 1996;17:921–933
  12. Dodart JC, Mathis C, Bales KR, Paul SM. Does my mouse have Alzheimer’s disease?. Genes Brain Behav. 2002;1(3):142–155
  13. Ely DL, Henry JP. Neuroendocrine response pattern in dominant and subordinate mice. Horm Behav. 1978;10:156–169
  14. Feng Z, Chang Y, Cheng Y, Zhang BL, Qu ZW, Qin C,, et al. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer’s disease. J Pineal Res. 2004;37:129–136
  15. Finkel SI. Behavioral and psychological symptoms of dementia. Clin Geriatr Med. 2003;19:724–799
  16. Furio AM, Cutrera RA, Thea VC, Lloret SP, Riccio P, Caccuri RL,, et al. Effect of melatonin on changes in locomotor activity rhythm of syrian hamsters injected with beta amyloid peptide 25–35 in the suprachiasmatic nuclei. Cell Mol Neurobiol. 2002;22(5/6):699–709
  17. Garner JP, Mason GJ. Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents. Behav Brain Res. 2002;136:83–92
  18. Gärtner K, Büttner D, Döhler K, Friedel R, Lindena J, Trautschold I. Stress response of rats to handling and experimental procedures. Lab Anim. 1980;14:267–274
  19. Gordon I, Ben-Eliyahu S, Rosenne E, Sehayek E, Michaelson DM. Derangement in stress response of apolipoprotein E-deficient mice. Neurosci Lett. 1996;206(2–3):212–214
  20. Gsell W, Jungkunz G, Riederer P. Functional neurochemistry of Alzheimer’s disease. Curr Pharm Des. 2004;10(3):265–293
  21. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356
  22. Harper DG, Stopa EG, McKee AC, Satlin A, Fish D, Volicer L. Dementia severity and lewy bodies affect circadian rhythms in Alzheimer disease. Neurobiol Aging. 2004;25(6):771–781
  23. Hatzinger M, Z’Brun A, Hemmeter U, Seifritz E, Baumann F, Holsboer-Tachsler E,, et al. Hypothalamic–pituitary–adrenal system function in patients with Alzheimer’s disease. Neurobiol Aging. 1995;16:205–209
  24. Heinrichs SC. Mouse feeding behavior: ethology, regulatory mechanisms and utility for mutant phenotyping. Behav Brain Res. 2001;125:81–88
  25. Hennessy MB, Levine S. Effects of various habituation procedures on pituitary–adrenal responsiveness in the mouse. Physiol Behav. 1977;18:799–802
  26. Higgins GA, Jacobsen H. Transgenic mouse models of Alzheimer’s disease: phenotype and application. Behav Pharm. 2003;14(5–6):419–438
  27. Huitron-Resendiz S, Sanchez-Alavez M, Gallegos R, Berg G, Crawford E, Giacchino JL,, et al. Age-independent and age-related deficits in visuospatial learning, sleep–wake states, thermoregulation and motor activity in PDAPP mice. Brain Res. 2002;928(1–2):126–137
  28. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD,, et al. A peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease. Nature. 2000;408(6815):979–982
  29. Joyce JN, Murray AM, Hurtig HI, Gottlieb GL, Trojanowski JQ. Loss of dopamine D2 receptors in Alzheimer’s disease with Parkinsonism but not in Parkinson’s or Alzheimer’s disease. Neuropsychopharmacology. 1998;19(6):472–480
  30. Jucker M, Walker LC, Schwarb P, Hengemihle J, Kuo H, Snow AD,, et al. Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice. Neuroscience. 1994;60(4):875–889
  31. Kemppainen N, Ruottinen H, Nagren K, Rinne JO. PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD. Neurology. 2000;55(2):205–209
  32. Kopp C. Locomotor activity rhythm in inbred strains of mice: implications for behavioural studies. Behav Brain Res. 2001;125:93–96
  33. Lalonde R, Dumont M, Staufenbiel M, Sturchler-Pierrat C, Strazielle C. Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res. 2002;956:36–44
  34. Lalonde R, Lewis TL, Strazielle C, Kim H, Fukuchi K. Transgenic mice expressing the betaAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination. Brain Res. 2003;977(1):38–45
  35. Maeda K, Tanimoto K, Terada T, Shintani T, Kakigi T. Elevated urinary free cortisol in patients with dementia. Neurobiol Aging. 1991;12:161–163
  36. Mahlberg R, Kunz D, Sutej I, Kühl KP, Hellweg R. Melatonin treatment of day–night rhythm disturbances and sundowning in Alzheimer disease. J Clin Psychopharmacol. 2004;24(4):456–458
  37. Martin P, Bateson P. Measuring behaviour: an introductory guide. 2nd ed. Cambridge: Cambridge University Press; 1993;
  38. Mason GJ. Stereotypies: a critical review. Anim Behav. 1991;41:1015–1037
  39. Mason GJ. Stereotypies and suffering. Behav Proc. 1991;25:103–115
  40. Matsubara E, Bryant-Thomas T, Quinto JP, Henry TL, Poeggeler B,, et al. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease. J Neurochem. 2003;85:1101–1108
  41. Meguro K, Meguro M, Tanaka Y, Akanuma K, Yamaguchi K, Itoh M. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer’s disease. J Geriatr Psychiatry Neurol. 2004;17(2):61–67
  42. Mishima K, Tozawa T, Satoh K, Matsumoto Y, Hishikawa Y, Okawa M. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking. Biol Psychiatry. 1999;45(4):417–421
  43. Nagatsu T, Levitt M, Udenfriend S. A rapid and simple radioassay for tyrosine hydroxylase activity. Anal Biochem. 1964;9:122–126
  44. Ohashi Y, Okamoto N, Uchida K, Iyo M, Mori N, Morita Y. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer’s type. Biol Psychiatry. 1999;45:1646–1652
  45. Palme R, Möstl E. Measurement of cortisol metabolites in faeces of sheep as a parameter of cortisol concentration in blood. Int J Mamm Biol. 1997;62(Suppl II):192–197
  46. Pani L, Porcella A, Gessa GL. The role of stress in the pathophysiology of the dopaminergic system. Mol Psychiatry. 2000;5:14–21
  47. Pedersen W, Culmsee C, Ziegler D, Herman J, Mattson M. Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer’s disease. J Mol Neurosci. 1999;13:159–165
  48. Piazza PV, Rougé-Pont F, Deroche V, Maccari S, Simon H, Le Moal M. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci USA. 1996;93:8716–8720
  49. Pizzolato G, Chierichetti F, Fabbri M, Cagnin A, Dam M, Ferlin G,, et al. Reduced striatal dopamine receptors in Alzheimer’s disease: Single photon emission tomography study with the D2 tracer123I-IBZM. Neurology. 1996;47(4):1065–1068
  50. Powell SB, Newman HA, Pendergast JF, Lewis MH. A rodent model of spontaneous stereotypy: initial characterization of developmental, environmental, and neurobiological factors. Physiol Behav. 1999;66(2):355–363
  51. Price DL, Tanzi RE, Borchelt DR, Sisodia SS. Alzheimer’s disease: genetic studies and transgenic models. Annu Rev Genet. 1998;32:461–493
  52. Ritchie K, Lovestone S. The dementias. Lancet. 2002;360(9347):1759–1766
  53. Robbins TW, Mittleman G, O’Brien J, Winn P. The neuropsychological significance of stereotypy induced by stimulant drugs. In: Cooper SJ, Dourish CT, editors. Neurobiology of stereotyped behaviour. Oxford: Clarendon Press; 1990. p. 25–63.
  54. Sachs L. Angewandte Statistik.. 10th ed. Berlin: Springer Verlag; 2002;
  55. Sachser N. What is important to achieve good welfare in animals? In: Broom DM, editor. Coping with challenge: welfare in animals including humans. Berlin: Dahlem University Press; 1993. p. 31–48.
  56. Sachser N, Lick C. Social stress in guinea pigs. Physiol Behav. 1989;46:137–144
  57. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986;75:284–301
  58. Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED,, et al. Human brain D1 and D2 dopmaine receptors in Schizophrenia, Alzheimer’s, Parkinson’s, and Huntington’s diseases. Neuropsychopharmacology. 1987;1(1):5–15
  59. Selkoe DJ. Alzheimer’s disease: genes, proteins and therapy. Physiol Rev. 2001;81(2):741–766
  60. Selkoe DJ. Alzheimer’s disease is a synaptic failure. Science. 2002;298:789–791
  61. Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. 2nd ed. New York: McGraw-Hill; 1988;
  62. Skene DJ, Swaab DF. Melatonin rhythmicity: effect of age and Alzheimer’s disease. Exp Gerontol. 2003;38:199–206
  63. Spackman DH, Riley V. Corticosterone concentrations in the mouse. Science. 1978;200:87
  64. Swaab DF, Dubelaar EJG, Hofman MA, Scherder EJA, van Someren EJW, Verwer RWH. Brain aging and Alzheimer’s disease; use it or lose it. In: Hofman MA, Boer GJ, Holtmaat AJGD, van Someren EJW, Verhaagen J, Swaab DF, editors. Progress in brain research, vol. 138. Elsevier Science B.V.; 2002. p. 343–73.
  65. Sweet RA, Hamilton RL, Lopez OL, Klunk WE, Wisniewski SR, Kaufer DI,, et al. Psychotic symptoms in Alzheimer’s disease are not associated with more severe neuropathologic features. Int Psychogeriatr. 2000;12(4):547–558
  66. Tanaka Y, Meguro K, Yamaguchi S, Ishi H, Watanuki S, Funaki Y,, et al. Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer’s disease. Ann Nucl Med. 2003;17(7):567–573
  67. Tate B, Aboody-Guterman KS, Morris AM, Walcott EC, Majocha RE, Marotta CA. Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid. Proc Natl Acad Sci USA. 1992;89(15):7090–7094
  68. Touma C, Ambrée O, Görtz N, Keyvani K, Lewejohann L, Palme R,, et al. Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer’s disease. Neurobiol Aging. 2004;25(7):893–904
  69. Touma C, Palme R, Sachser N. Analyzing corticosterone metabolites in fecal samples of mice: a noninvasive technique to monitor stress hormones. Horm Behav. 2004;45(1):10–22
  70. Touma C, Sachser N, Möstl E, Palme R. Effects of sex and time of day on metabolism and excretion of corticosterone in urine and feces of mice. Gen Comp Endocrinol. 2003;130(3):267–278
  71. Van Dam D, D’Hooge R, Staufenbiel M, Van Ginneken C, Van Meir F, De Deyn PP. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci. 2003;17(2):388–396
  72. van Someren EJ, Hagebeuk EE, Lijzenga C, Scheltens P, de Rooij SE, Jonker C. Circadian rest-activity rhythm disturbances in Alzheimer’s disease. Biol Psychiatry. 1996;40(4):259–270
  73. van Someren EJW. Circadian and sleep disturbances in the elderly. Exp Gerontol. 2000;35:1229–1237
  74. Vloeberghs E, van Dam D, Engelborghs S, Nagels G, Staufenbiel M, de Deyn PP. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances. Eur J Neurosci. 2004;200:2757–2766
  75. Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer’s disease. Am J Psychiatry. 2001;158(5):704–711
  76. von Holst D. The concept of stress and its relevance for animal behavior. Adv Study Behav. 1998;27:1–131
  77. Witte PU, Matthaei H. Mikrochemische Methoden für neurobiologische Untersuchungen. Berlin: Springer Verlag; 1980;
  78. Witting W, Kwa IH, Eikelenboom P, Mirmiran M, Swaab DF. Alterations in the circadian rest-activity rhythm in aging and Alzheimer’s disease. Biol Psychiatry. 1990;27(6):563–572
  79. Wu YH, Feenstra MGP , Zhou JN, Liu RY, Torano JS, van Kan HJM,, et al. Molecular changes underlying reduced pineal melatonin levels in Alzheimer’s disease: alterations in preclinical and clinical stages. J Clin Endocr Metab. 2003;88(12):5898–5906
  80. Würbel H, Chapman R, Rutland C. Effect of feed and environmental enrichment on development of stereotypic wire-gnawing in laboratory mice. Appl Anim Behav Sci. 1998;60:69–81
  81. Würbel H, Stauffacher M, von Holst D. Stereotypies in laboratory mice – quantitative and qualitative description of the ontogeny of ‘wire-gnawing’ and ‘jumping’ in Zur:ICR and Zur:ICR nu. Ethology. 1996;102:371–385

PII: S0197-4580(05)00145-4

doi: 10.1016/j.neurobiolaging.2005.05.009

Neurobiology of Aging
Volume 27, Issue 7 , Pages 955-964 , July 2006

Article Tools

* Image Usage & Resolution